Proteasomes as Drug Targets
Journal:
Current Drug Targets
Volume:
4
Page:
656-670
Author(s):
Marco Piccinini, Michael Mostert and Maria Teresa Rinaudo
Aspects of the Stability and Bioavailability of Carbohydrates and Carbohydrate Derivatives
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
633-649
Author(s):
N. B. Drinnan and Frank Vari
GnRH Agonists and Antagonists in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
399-410
Author(s):
Murty V. Chengalvala, Jeffrey C. Pelletier and Gregory S. Kopf
Safety and Utilization of Blood Components as Therapeutic Delivery Systems
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
275-282
Author(s):
Tiffany Adams, Fars Alanazi and D. Robert Lu
Silence of the Genes: A Targeted Approach to the Suppression of Specific Genes in Human Disease Using Small Interfering RNA (siRNA)
Journal:
Current Genomics
Volume:
4
Page:
587-598
Author(s):
Jim Apostolopoulos
Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
452-467
Author(s):
Lily Wu and Makoto Sato
Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2024-2035
Author(s):
M. Schaffer, B. Ertl-Wagner, P. M. Schaffer, U. Kulka, A. Hofstetter, E. Duhmke and G. Jori
Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2067-2077
Author(s):
J. Brtko and J. Thalhamer
Prodrugs in Genetic Chemoradiotherapy
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2131-2154
Author(s):
Adam V. Patterson, Mark P. Saunders and Olga Greco
Cyclooxygenase-2 Biology
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2177-2190
Author(s):
Joan Claria